 |
|
Global epidemiology of alcohol-related liver disease, liver cancer, and alcohol use disorder, 2000–2021
Pojsakorn Danpanichkul, Luis Antonio Díaz, Kanokphong Suparan, Primrose Tothanarungroj, Supapitch Sirimangklanurak, Thanida Auttapracha, Hanna L. Blaney, Banthoon Sukphutanan, Yanfang Pang, Siwanart Kongarin, Francisco Idalsoaga, Eduardo Fuentes-López, Lorenzo Leggio, Mazen Noureddin, Trenton M. White, Alexandre Louvet, Philippe Mathurin, Rohit Loomba, Patrick S. Kamath, Jürgen Rehm, Jeffrey V. Lazarus, Karn Wijarnpreecha, Juan Pablo Arab
Clin Mol Hepatol. 2025;31(2):525-547. Published online 2025 Jan 9 DOI: https://doi.org/10.3350/cmh.2024.0835
|
|
Citations to this article as recorded by
 Letter: Global Burden of Metabolic Dysfunction‐Associated Steatotic Liver Disease‐Related Liver Cancer—Results From the Global Burden of Disease Study 2021. Authors' Reply
Pojsakorn Danpanichkul, Donghee Kim, Markos Kalligeros, Amit G. Singal, Ju Dong Yang, Karn Wijarnpreecha
Alimentary Pharmacology & Therapeutics.2025; 61(6): 1080. CrossRef Updated recommendations for the management of metabolic dysfunction–associated steatotic liver disease (MASLD) by the Latin American working group
Luis Antonio Diaz, Juan Pablo Arab, Francisco Idalsoaga, Javiera Perelli, Javier Vega, Melisa Dirchwolf, Javiera Carreño, Bárbara Samith, Cynthia Valério, Rodrigo Oliveira Moreira, Mónica Acevedo, Javier Brahm, Nelia Hernández, Adrian Gadano, Claudia P. O
Annals of Hepatology.2025; 30(2): 101903. CrossRef Editorial: Balancing the Yin and Yang of Alcohol‐Associated Liver Disease—Integrating Pathophysiology, Liver‐Directed Therapy, and Addiction Management. Authors' Reply
Luis Antonio Díaz, Rohit Loomba
Alimentary Pharmacology & Therapeutics.2025; 61(7): 1256. CrossRef Implementing public health policy to tackle alcohol-related harms
Pojsakorn Danpanichkul, Karn Wijarnpreecha
The Lancet Public Health.2025; 10(5): e350. CrossRef Alcohol-Associated Liver Disease and Risk Stratification for Hepatocellular Carcinoma: A Comprehensive Review
Jaeyoun Choi, Hyun-seok Kim
Current Hepatology Reports.2025;[Epub] CrossRef Public Health Policies and Strategies to Prevent Alcohol-Related Morbidity and Mortality
Roba El Zibaoui, Luis Antonio Díaz, Francisco Idalsoaga, Juan Pablo Arab
Current Hepatology Reports.2025;[Epub] CrossRef Tetramethylpyrazine: A fermented alcohol product that mitigates alcoholic liver disease in mice
Qing Pu, Han Gao, Dake Xiao, Manyuan Wang, Zhiyun Yang, Qiang He, Min Liu, Xuejin Zhu, Tao Pan, Zhitao Ma, Jiabo Wang, Yao Liu
Free Radical Biology and Medicine.2025; 236: 160. CrossRef Disproportionately rising mortality rates of alcohol-associated acute Pancreatitis: Analysis from centers for Disease Control and prevention database (2011–2020)
Pojsakorn Danpanichkul, Yanfang Pang, Donghee Kim, Thanida Auttapracha, Shu-Yen Chan, Do Han Kim, Thanawin Pramotedham, Kanita Mankan, Chanokporn Puchongmart, Juan Pablo Arab, Luis Antonio Diaz, Jorge D. Machicado, Michael B. Wallace, Karn Wijarnpreecha
Pancreatology.2025; 25(4): 508. CrossRef Safety and Tolerability of Injectable Extended‐Release Naltrexone for the Management of Alcohol Use Disorder in Advanced Alcohol‐Associated Liver Disease
Luis Antonio Díaz, Summer Collier, Jeffrey Yin, Rohit Loomba
Alimentary Pharmacology & Therapeutics.2025;[Epub] CrossRef Osteoporosis is associated with increased CVD mortality and all-cause mortality in alcohol-consuming individuals: A cohort study using data from NHANES
Xiaoqin Qu, Jingcheng Jiang, Qian Wu,
PLOS One.2025; 20(6): e0327180. CrossRef Fabrication of camptothecin and gold nanoparticles encapsulated liposomes for synergic anticancer therapy in liver cancer cells
Hengyang Wang, Jingjian Ding, Tao Wang, Kongliang Luo
Particulate Science and Technology.2025; : 1. CrossRef
|